Inclusion Criteria : 
  -  Diagnosed diabetes mellitus and treatment - naÃ¯ve CI - DME requiring anti - VEGF therapy per retinal specialist's customary treatment regimen will be recruited to participate in the study.  CI - DME will be defined as a central subfield thickness ( CST ) > 300 microns on spectral domain optical coherence tomography ( SD - OCT ) or CST > 250 microns with definite intra - retinal cystic fluid accumulation.  Additional inclusion criteria are age > 18 years , and ability to give informed consent. 
Exclusion Criteria : 
  -  Age < 18 years , inability to give informed consent , evidence of proliferative diabetic retinopathy , evidence of other serious ocular disease ( age - related macular degeneration , glaucoma , significant media opacity )  , history of previous intraocular surgery , including macular or panretinal photocoagulation ( except uncomplicated cataract or keratorefractive surgery more than 6 months prior to enrollment )  , pregnant and nursing women , known sensitivity to any of the supplement ingredients.